Annovis Bio Welcomes Four New Executives to Strengthen Leadership Team

MALVERN, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), is pleased to announce the addition of four accomplished professionals to its executive team. 

Read more at globenewswire.com